Unigold Grants Director Options

Unigold (TSXV: UGD / OTC: UGDIF) announced the board approved incentive stock option grants to new directors for an aggregate of up to 600,000 common shares at an exercise price of $0.45 per share, expiring on April 28, 2031.

Rhea-AI Summary

Unigold (TSXV: UGD / OTC: UGDIF) announced the board approved incentive stock option grants to new directors for an aggregate of up to 600,000 common shares at an exercise price of $0.45 per share, expiring on April 28, 2031.

The grants are issued under the company stock incentive plan and subject to TSX Venture Exchange policies.

Positive

• Options granted for an aggregate of 600,000 common shares
• Fixed exercise price of $0.45 per share for option holders

Negative

• Potential shareholder dilution if up to 600,000 options are exercised
• Options carry a five-year term to expiry (April 28, 2031)

Argus Apr 29 session

-8.00% close to close Open Argus

Details

News Market Reaction – UGDIF

On Apr 29, the first trading day after this news, UGDIF closed 8.00% below the previous close.

Data tracked by StockTitan Argus for the Apr 29 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Toronto, Ontario--(Newsfile Corp. - April 28, 2026) - Unigold Inc. (TSXV: UGD) (OTC Pink: UGDIF) (FSE: UGB1) ("Unigold" or the "Company") announces that the Board of Directors has approved the grant of incentive stock options ("Options") to new directors allowing for the acquisition of an aggregate of up to 600,000 common shares of the Company with an exercise price of $0.45 per common share and an expiry date of April 28, 2031. The grants of Options were issued pursuant and subject to the terms and conditions of the Company's stock incentive plan and TSX Venture Exchange policies.

For further information please visit http://www.unigoldinc.com or contact:

Mr. Joseph Hamilton
Chairman & CEO
T. (416) 866-8157

Forward-looking Statements
Certain statements contained in this document, including statements regarding events and financial trends that may affect our future operating results, financial position and cash flows, may constitute forward-looking statements within the meaning of the federal securities laws. The forward-looking statements contained in this document are made as of the date hereof and we assume no obligation to update the forward-looking statements Where applicable, we claim the protection of the safe harbour for forward-looking statements provided by the (United States) Private Securities Litigation Reform Act of 1995. For more information, please visit https://www.unigoldinc.com/profile/forward-looking-statement.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294714

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Unigold (UGDIF) announce on April 28, 2026 about director compensation?

Unigold granted incentive stock options to new directors for up to 600,000 shares. According to the company, the options carry a $0.45 exercise price and expire on April 28, 2031, and are subject to the stock plan and TSXV policies.

How many shares could be issued if Unigold director options (UGDIF) are exercised?

If exercised in full, the options could issue up to 600,000 common shares. According to the company, issuance depends on option exercise decisions and compliance with the stock incentive plan and TSXV rules.

What is the exercise price and expiry for Unigold director options (UGDIF)?

The options carry an exercise price of $0.45 per share and expire on April 28, 2031. According to the company, grants were made under its stock incentive plan and are subject to TSXV policies.

Will the Unigold director option grants (UGDIF) require regulatory approval?

The grants are subject to TSX Venture Exchange policies and the company stock incentive plan. According to the company, compliance with TSXV rules applies but the announcement does not state any outstanding approvals.

What shareholder impact should investors consider from Unigold's (UGDIF) option grants?

Investors should note potential dilution if options are exercised for up to 600,000 shares. According to the company, the options have a $0.45 exercise price and five-year expiry, with issuance governed by the stock plan and TSXV policies.